Recent studies suggest
that exposure to endocrine-disrupting compounds
(EDCs) may play a role in the development of obesity. EDCs such as
the flame retardant 2,2′,4,4′-tetrabrominated diphenyl
ether (BDE-47) have been shown to enhance adipocyte differentiation
in the murine 3T3-L1 model. The mechanisms by which EDCs direct preadipocytes
to form adipocytes are poorly understood. Here, we examined transcriptional
and epigenetic mechanisms underlying the induction of in vitro adipocyte
differentiation by BDE-47. Quantitative high content microscopy revealed
concentration-dependent enhanced adipocyte differentiation following
exposure to BDE-47 or the antidiabetic drug troglitazone (TROG). BDE-47
modestly activated the key adipogenic transcription factor peroxisome
proliferator-activated receptor gamma (PPARγ) in COS7 cells,
transiently transfected with a GAL4 reporter construct. Increased
gene expression was observed for Pparγ2, leptin
(Lep), and glucose-6-phophatase catalytic subunit
(G6pc) in differentiated 3T3-L1 cells after BDE-47
exposure compared to TROG. Methylation-sensitive high resolution melting
(MS-HRM) revealed significant demethylation of three CpG sites in
the Pparγ2 promoter after exposure to both
BDE-47 and TROG in differentiated 3T3-L1 cells. This study shows the
potential of BDE-47 to induce adipocyte differentiation through various
mechanisms that include Pparγ2 gene induction
and promoter demethylation accompanied by activation of PPARγ,
and possible disruption of glucose homeostasis and IGF1 signaling.